New update:
First, It is commonly believed that the current FDA status of NMN is the same as CBD.
Yesterday, the FDA took a step against CBD
and declined three citizen petitions that had asked for a rulemaking to allow the marketing of CBD products as dietary supplements. The U.S. Food and Drug Administration has concluded that a new regulatory pathway for CBD products is needed to balance individuals' access to them with the regulatory oversight required to manage risks. They claim CBD can potentially harm the liver and interactions with certain meds and the male reproductive system.
https://www.fda.gov/...ate-cannabidiol
In my personal opinion,
they want to set it up for Congress, so Congress can spike the ball and give the FDA a regulations power grab. I don't see how the FDA needs a different regulatory framework for CBD that they don't already have for other products, like alcohol. I don't believe this is about CBD anymore, but a way for Dick Durbin to choke Dietary Supplement companies through costly regulations and hand over more business to big pharma.
Coming back to the NMN,
current studies show no adverse effects on people (which was the case with CBD and the main reason the FDA says they needed more regulations from Congress and denied a citizen's petition). Now the FDA is still open to getting information from people that show purchases in 2018 and before, where the labels include "Nutritional Facts" rather than "Supplement Facts" on the label or say "Food Supplement" on the bottle.
If you have purchased anything and have an email record of it, purchase or marketing with an NMN product with this information on the label. Let me know or email me. The FDA has to consider the marketing of this type to determine whether NMN can be sold to the public without issues.
Much like all the ingredients that DSHEA grandfathered in, they needed to show they were marketed to the public before the FDA rules took effect. NMN product marketing and sales need to be shown to the FDA similarly, proving that it was sold before the IND paperwork was filed with the FDA.
A